Matches in Nanopublications for { ?s ?p "[CYP2J2 Tr mice exhibit increased expression of phospho-p42/p44 mitogen-activated protein kinase (MAPK) after ischemia, and addition of the p42/p44 MAPK kinase (MEK) inhibitor PD98059 during reperfusion abolishes the cardioprotective effects of CYP2J2 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP477840.RAcxxQJx8fIxG8U9jpX14IHes4c8OmWRscvpvd6X0Vl1w130_assertion description "[CYP2J2 Tr mice exhibit increased expression of phospho-p42/p44 mitogen-activated protein kinase (MAPK) after ischemia, and addition of the p42/p44 MAPK kinase (MEK) inhibitor PD98059 during reperfusion abolishes the cardioprotective effects of CYP2J2 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP477840.RAcxxQJx8fIxG8U9jpX14IHes4c8OmWRscvpvd6X0Vl1w130_provenance.
- NP192952.RARhbe8ydPedmx0erT8uAulHO6AKc1zC_eBZyymTAIjDY130_assertion description "[CYP2J2 Tr mice exhibit increased expression of phospho-p42/p44 mitogen-activated protein kinase (MAPK) after ischemia, and addition of the p42/p44 MAPK kinase (MEK) inhibitor PD98059 during reperfusion abolishes the cardioprotective effects of CYP2J2 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP192952.RARhbe8ydPedmx0erT8uAulHO6AKc1zC_eBZyymTAIjDY130_provenance.
- NP515144.RAm6osINgxEYOgdm1ivhdvMVeYRFmv85ATMmALduWGHFk130_assertion description "[CYP2J2 Tr mice exhibit increased expression of phospho-p42/p44 mitogen-activated protein kinase (MAPK) after ischemia, and addition of the p42/p44 MAPK kinase (MEK) inhibitor PD98059 during reperfusion abolishes the cardioprotective effects of CYP2J2 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515144.RAm6osINgxEYOgdm1ivhdvMVeYRFmv85ATMmALduWGHFk130_provenance.
- NP419980.RAk4JwJCge-VcqbbCI66WTjqhJBhmx9xZE1c9cP4KJz9g130_assertion description "[CYP2J2 Tr mice exhibit increased expression of phospho-p42/p44 mitogen-activated protein kinase (MAPK) after ischemia, and addition of the p42/p44 MAPK kinase (MEK) inhibitor PD98059 during reperfusion abolishes the cardioprotective effects of CYP2J2 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419980.RAk4JwJCge-VcqbbCI66WTjqhJBhmx9xZE1c9cP4KJz9g130_provenance.
- NP536696.RAm8G9luDyRs5pbxgNcaMimFjMORHLRI1oR8mW-ubQTm8130_assertion description "[CYP2J2 Tr mice exhibit increased expression of phospho-p42/p44 mitogen-activated protein kinase (MAPK) after ischemia, and addition of the p42/p44 MAPK kinase (MEK) inhibitor PD98059 during reperfusion abolishes the cardioprotective effects of CYP2J2 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP536696.RAm8G9luDyRs5pbxgNcaMimFjMORHLRI1oR8mW-ubQTm8130_provenance.
- NP592514.RAYervnv-V_yOoyHWi6_fqHzdHzz-euD34D5plRfDYMt4130_assertion description "[CYP2J2 Tr mice exhibit increased expression of phospho-p42/p44 mitogen-activated protein kinase (MAPK) after ischemia, and addition of the p42/p44 MAPK kinase (MEK) inhibitor PD98059 during reperfusion abolishes the cardioprotective effects of CYP2J2 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP592514.RAYervnv-V_yOoyHWi6_fqHzdHzz-euD34D5plRfDYMt4130_provenance.
- NP154763.RAEH1IosDBRMPjtuT_tEe-VFxNsHJHqTWx-PIZvN0uzAU130_assertion description "[CYP2J2 Tr mice exhibit increased expression of phospho-p42/p44 mitogen-activated protein kinase (MAPK) after ischemia, and addition of the p42/p44 MAPK kinase (MEK) inhibitor PD98059 during reperfusion abolishes the cardioprotective effects of CYP2J2 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP154763.RAEH1IosDBRMPjtuT_tEe-VFxNsHJHqTWx-PIZvN0uzAU130_provenance.
- NP564315.RA4ivUj4V6phbiKXewVYy3eRm154ExOEdpFHGg8gOkABg130_assertion description "[CYP2J2 Tr mice exhibit increased expression of phospho-p42/p44 mitogen-activated protein kinase (MAPK) after ischemia, and addition of the p42/p44 MAPK kinase (MEK) inhibitor PD98059 during reperfusion abolishes the cardioprotective effects of CYP2J2 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP564315.RA4ivUj4V6phbiKXewVYy3eRm154ExOEdpFHGg8gOkABg130_provenance.
- NP911935.RA4yKXzagyWiS2u42RGZ7mDKhvD9enpyMTRU0OhlcPj54130_assertion description "[CYP2J2 Tr mice exhibit increased expression of phospho-p42/p44 mitogen-activated protein kinase (MAPK) after ischemia, and addition of the p42/p44 MAPK kinase (MEK) inhibitor PD98059 during reperfusion abolishes the cardioprotective effects of CYP2J2 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP911935.RA4yKXzagyWiS2u42RGZ7mDKhvD9enpyMTRU0OhlcPj54130_provenance.